Eli Lilly to Acquire Centessa Pharmaceuticals for Up to $7.8 Billion
Eli Lilly announced its intention to acquire Centessa Pharmaceuticals for up to $7.8 billion, a deal aimed at bolstering its portfolio of sleep medicines and narcolepsy drugs, with the acquisition expected to close in the third quarter. Reports indicate the deal could be valued at $6.3 billion or up to $7.8 billion.
The Story
Analyzing sources…
Source Diversity
Source Diversity
High (71/100)Sources
Lilly seals up to $7.8 billion deal for Centessa in sleep disorder bet - Reuters
Lilly seals up to $7.8 billion deal for Centessa in sleep disorder bet Reuters
Read full article →Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
By Rebecca Robbins
Read full article →Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult for people to stay awake.
Read full article →Lilly to pay up to $7.8 billion to buy a company developing a narcolepsy drug
The company, which is flush with cash from sales of its market-leading GLP-1 franchise, has been an active dealmaker.
By Jaimy Lee
Read full article →Eli Lilly to acquire Centessa in $6.3B deal to expand neuroscience portfolio
Read full article →Coverage Timeline
Related Stories
Most local governments underspend on primary healthcare – study
just now
Philippine DOH Officials Sued Over P1.5-B Expired Drugs and Vaccines
just now
11-Year-Old Asks Philippine President Marcos Jr. About Sexual Injustices
2m ago
Icelandic Health Minister Approves Conversion of Residential Rooms to Nursing Home Beds
20m ago